Known to ease motor fluctuations due to “off periods” in Parkinson’s disease, daily use of Xadago (safinamide) at low dose also appears to significantly decrease such non-motor symptoms as apathy, while improving patients’ sense of motivation and interest over six months, a real-life study reported. The…
News
A new biobank in Sweden, containing blood samples from patients with Parkinson’s disease and age- and sex-matched healthy people — along with data regarding the individuals’ lifestyles and medical histories — may help researchers investigate the underlying mechanisms of the neurodegenerative disorder and find new treatments. The biobank is…
New exercise recommendations have been released by the Parkinson’s Foundation and the American College of Sports Medicine (ACSM) to provide effective and safe guidelines about physical activity for people with Parkinson’s disease and…
Levodopa, a standard treatment for Parkinson’s disease, reached the brain faster when given as a gel into the nasal cavity than as an intravenous (into-the-vein) injection, a new mouse study shows. The findings support the potential of intranasal administration as a way to reach the brain and bypass…
Whole-body electromyostimulation (WB-EMS) to trigger muscle contractions, improved upper and lower body strength, endurance, and hand-eye coordination in a small group of people with early Parkinson’s disease who did not engage in regular exercise programs. The study with that finding, “…
Computer algorithms used to analyze large medical databases found an early diagnosis of walking difficulties or tremors best predicted a future diagnosis of Parkinson’s disease, a study found. The study, “Accelerating diagnosis of Parkinson’s disease through…
Creative Medical Technology Holdings has extended the applications of its investigational “regenerative immunotherapy” ImmCelz to include Parkinson’s disease, after seeing positive preclinical data from a mouse model of the disease, according to a company press release. ImmCelz inhibited the onset of Parkinson’s symptoms in a mouse model of the…
People with Parkinson’s disease who are hospitalized with COVID-19Â may have a greater risk for more severe infections and higher mortality, according to a recent study of German hospital records. The study, “Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson’s Disease in Germany,” was published…
Swallowing difficulties seem to be associated with progression of Parkinson’s disease, a study has found. Researchers found that high doses of levodopa can increase xerostomia — or dry mouth — and negatively affect the oral environment. Moreover, people with Parkinson’s seem to be unaware of their swallowing difficulties, which could lead to…
The Parkinson’s Foundation has received a $30,000 grant from the National Endowment for the Arts (NEA) to support a photo exhibition by Los Angeles-based artist Safi Alia Shabaik documenting her father’s journey with Parkinson’s disease. “I am humbled and elated by the NEA’s thoughtful recognition of this project…
Recent Posts
- Blocking 2 proteins could slow Parkinson’s progression: Study
- How to minimize stress while traveling with Parkinson’s disease
- New PET tracer helps scientists ‘see’ Parkinson’s toxic protein clumps
- Tech duo to advance brain-penetrating drugs for CNS disorders
- New trial offers extended buntanetap access for people with Parkinson’s